SUPERHUMAN\u2122 MEDICAL WEIGHT LOSS
Ozempic & Wegovy (Semaglutide): Complete Guide for Weight Loss in India
Everything You Need to Know About India's Most Searched Weight Loss Medications
Consult Doctor for Semaglutide
UNDERSTANDING SEMAGLUTIDE
What are Ozempic and Wegovy? Understanding Semaglutide
Ozempic and Wegovy are brand names for semaglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk. Both medications contain the same active ingredient but are approved for different primary indications and at different doses.
| Feature | Ozempic | Wegovy |
|---|---|---|
| Generic Name | Semaglutide | Semaglutide |
| Primary Approval | Type 2 Diabetes | Chronic Weight Management |
| Max Dose | 2.0 mg weekly | 2.4 mg weekly |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
Osenpick, Ozentic, Ozampic, Wegovy, Wygovy, Ozampik — all refer to semaglutide-based medications.
MECHANISM OF ACTION
How Does Semaglutide Injection Work?
Semaglutide mimics the GLP-1 hormone, acting on five key systems to reduce weight. Here is exactly what happens inside your body after each weekly injection.
| Target | What Semaglutide Does | What You Feel |
|---|---|---|
| Brain (Hypothalamus) | Hunger signals reduced | Eat less without willpower |
| Stomach | Gastric emptying slows | Full longer after meals |
| Liver | Glucagon production reduced | Less sugar released into blood |
| Pancreas | Insulin secretion improved | Better blood sugar control |
| Fat Cells | Visceral fat targeted | Belly fat reduction |
HEAD-TO-HEAD COMPARISON
Ozempic vs Wegovy: Which is Right for You?
Both contain semaglutide but are prescribed differently. Here is a clinical comparison to help you and your doctor decide.
| Parameter | Ozempic | Wegovy |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| FDA Approval | Type 2 Diabetes (2017) | Chronic Weight Management (2021) |
| Starting Dose | 0.25 mg weekly | 0.25 mg weekly |
| Maintenance Dose | 0.5 – 2.0 mg weekly | 2.4 mg weekly |
| Weight Loss Focus | Secondary benefit | Primary indication |
| Diabetes Benefit | Primary indication | Secondary benefit |
| India Availability | Widely available | Limited availability |
EVIDENCE-BASED MEDICINE
What the Clinical Trials Show
Semaglutide is one of the most studied weight-loss medications in history. Here are the key results from landmark trials.
Semaglutide 2.4 mg achieved 14.9% mean body weight reduction vs 2.4% with placebo at 68 weeks. One-third of participants lost more than 20% of their body weight. This was the trial that established semaglutide as a serious weight-loss medication.
DermaVue Semaglutide Dose Titration Protocol
| Period | Weekly Dose | Purpose |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Initiation — body adjustment |
| Weeks 5–8 | 0.5 mg | Early dose escalation |
| Weeks 9–12 | 1.0 mg | Therapeutic level — appetite suppression begins |
| Weeks 13–16 | 1.7 mg | Advanced titration |
| Week 17+ | 2.0–2.4 mg | Full maintenance dose |
DERMATOLOGIST-LED ADVANTAGE
Ozempic Face: What It Is and How DermaVue Prevents It
"Ozempic Face" refers to the gaunt, aged facial appearance caused by rapid facial fat loss during GLP-1 therapy. Volume loss in the cheeks, temples, and under-eyes can make patients look older even as their body gets leaner. This is the number one cosmetic concern with semaglutide treatment.
DermaVue Face-Saver Protocol
Month 1 — Oral Collagen + Retinol
Collagen peptide supplementation to support dermal matrix, medical-grade retinol to stimulate fibroblast activity and maintain skin thickness.
Month 2 — Profhilo Bio-Remodeling
Injectable hyaluronic acid bio-remodeling to restore deep hydration and stimulate collagen and elastin production across the mid-face.
Month 3 — Polynucleotides (PDRN)
Polydeoxyribonucleotide injections to regenerate skin tissue, improve elasticity, and counteract the volume-loss effects of rapid weight reduction.
Month 6+ — MFU-V / Ultherapy (if indicated)
Micro-focused ultrasound with visualisation for non-surgical lifting and tightening of lax skin, assessed on a case-by-case basis.
No other weight loss clinic in Kerala provides built-in dermatological protection against Ozempic Face. Because DermaVue is a dermatology clinic first, we proactively protect your skin and face while you lose weight.
HONEST COMPARISON
Semaglutide vs Tirzepatide: Honest Comparison
At DermaVue, Mounjaro (tirzepatide) is our preferred first-line medication for most patients due to superior clinical outcomes. Ozempic/semaglutide is recommended for patients with specific clinical indications, budget considerations, or thin-fat phenotype without high insulin resistance.
| Parameter | Semaglutide (Ozempic/Wegovy) | Tirzepatide (Mounjaro) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist (single) | Dual GIP + GLP-1 receptor agonist |
| Weight Loss % | ~14.9% (STEP 1) | ~22.5% (SURMOUNT-1) |
| SURMOUNT-5 Result | 13.7% body weight reduction | 20.2% body weight reduction |
| India Availability | Widely available (branded + generic) | Available |
| DermaVue Recommendation | Specific clinical indications, budget-conscious, thin-fat phenotype | First-line for most patients |
SAFETY & TOLERABILITY
Managing Semaglutide Side Effects
Most side effects are gastrointestinal, mild to moderate in severity, and resolve within 4–8 weeks of continued use. Slow dose titration at DermaVue significantly reduces the frequency and severity of these effects.
| Side Effect | Frequency | DermaVue Management |
|---|---|---|
| Nausea | ~44% | Slow titration, smaller meals, avoid fatty foods, ondansetron if severe |
| Vomiting | ~24% | Anti-emetics as needed, hydration support, dose hold if persistent |
| Constipation | ~24% | Fibre supplementation, hydration, stool softeners if indicated |
| Diarrhoea | ~30% | Dietary adjustment, electrolyte monitoring, usually self-limiting |
Side effects usually resolve within 4–8 weeks. DermaVue's 5-step dose titration protocol is specifically designed to minimise gastrointestinal side effects during the adjustment period.
AVAILABILITY
Semaglutide Availability in India
Semaglutide is available in India in both branded (Ozempic, Wegovy) and generic formulations. Your DermaVue doctor will prescribe the most appropriate option based on your clinical needs.
Medication pricing varies by type and dose. Your doctor will discuss options during your consultation. DermaVue does not sell medications directly — prescriptions are provided after clinical evaluation and medications are purchased from licensed pharmacies.
FREQUENTLY ASKED QUESTIONS
Ozempic & Wegovy FAQ
Doctor-verified answers to the most common questions about semaglutide for weight loss.
DERMAVUE SUPERHUMAN PROGRAM
Ready to Start Your SuperHuman Journey?
Talk to a doctor — free 10-minute WhatsApp consultation
★ 4.8 rating · 7,200+ patients · Dermatologist-led program
